missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. LSP1 Mouse anti-Human, Clone: LSP1/3042, Novus Biologicals™
  7. 18617747

LSP1 Mouse anti-Human, Clone: LSP1/3042, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-07254-100ug

 View more versions of this product

Product Code. 18617747

  • 484.00€ / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

LSP1 Monoclonal specifically detects LSP1 in Human samples. It is validated for ELISA, Protein Array.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

LSP1
Monoclonal
0.2 mg/mL
ELISA, Protein Array
47 kDa actin binding protein, 47 kDa actin-binding protein, 52 kDa phosphoprotein, F-actin binding and cytoskeleton associated protein, leufactin (leukocyte F-actin binding protein), leukocyte-specific protein 1, lymphocyte-specific protein 1, lymphocyte-specific protein pp52, pp52, WP34Lymphocyte-specific antigen WP34
Recombinant fragment of human LSP1 protein (around aa174-278) (exact sequence is proprietary)
100 μg
Phospho Specific
4046
Store at 4°C.
IgG1 κ
ELISA, Peptide Array
LSP1/3042
Unconjugated
10 mM PBS with 0.05% BSA
Mouse
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.